Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Italy
Content Channel
Biogen investigated by Italian regulator on ‘market abuse’ claims
Italy’s antitrust agency is investigating Biogen over claims it is abusing its market position regarding a test for MS drug Tysabri.
Ben Adams
May 27, 2026 7:38am
Chiesi grows rare disease ambitions with $1.9B KalVista buyout
Apr 29, 2026 10:01am
CDMO Axplora to pump $60M into Italian complex API plant
Mar 19, 2026 8:50am
Chiesi unveils €430M investment in new Italian inhaler facility
Mar 27, 2025 10:47am
CDMO industry projects growth, spurns BIOSECURE: CPHI research
Sep 30, 2024 10:42am
J&J plugs €580M into Italy operations
Jun 20, 2024 9:12am
